Optimal treatment includes consideration of both safety (bleeding) and efficacy (reduction in death and MI). Assessment of bleeding risk with the CRUSADE Bleeding Score may complement existing ischemic risk stratification tools (i.e. TIMI, PURSUIT, or GRACE ACS Risk Score) for global risk stratification of the NSTEMI patient. The following links are to websites that provide risk prediction tools to estimate a patient's risk for death or MI.
GRACE ACS Risk Model: